206 related articles for article (PubMed ID: 29684108)
1. Pituitary Diseases and Bone.
Mazziotti G; Frara S; Giustina A
Endocr Rev; 2018 Aug; 39(4):440-488. PubMed ID: 29684108
[TBL] [Abstract][Full Text] [Related]
2. Pituitary diseases and bone.
Mazziotti G; Chiavistelli S; Giustina A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):171-80. PubMed ID: 25732653
[TBL] [Abstract][Full Text] [Related]
3. Update on vertebral fractures in pituitary diseases: from research to clinical practice.
Carrone F; Ariano S; Piccini S; Milani D; Mirani M; Balzarini L; Lania AG; Mazziotti G
Hormones (Athens); 2021 Sep; 20(3):423-437. PubMed ID: 33606197
[TBL] [Abstract][Full Text] [Related]
4. Acromegalic osteopathy.
Mazziotti G; Maffezzoni F; Frara S; Giustina A
Pituitary; 2017 Feb; 20(1):63-69. PubMed ID: 27709412
[TBL] [Abstract][Full Text] [Related]
5. Measurement of Bone: Diagnosis of SCI-Induced Osteoporosis and Fracture Risk Prediction.
Troy KL; Morse LR
Top Spinal Cord Inj Rehabil; 2015; 21(4):267-74. PubMed ID: 26689691
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and therapeutic approach to bone health in patients with hypopituitarism.
Kuliczkowska-Płaksej J; Zdrojowy-Wełna A; Jawiarczyk-Przybyłowska A; Gojny Ł; Bolanowski M
Rev Endocr Metab Disord; 2024 Jun; 25(3):513-539. PubMed ID: 38565758
[TBL] [Abstract][Full Text] [Related]
7. New tools for bone health assessment in secreting pituitary adenomas.
Uygur MM; Frara S; di Filippo L; Giustina A
Trends Endocrinol Metab; 2023 Apr; 34(4):231-242. PubMed ID: 36869001
[TBL] [Abstract][Full Text] [Related]
8. Bone disease in CKD.
Ott SM
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):376-81. PubMed ID: 22531161
[TBL] [Abstract][Full Text] [Related]
9. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
Iwasaki Y; Kazama JJ; Fukagawa M
Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic challenges in osteoporosis. Indications for bone densitometry and establishing secondary causes.
Karsh J
Can Fam Physician; 2001 Jun; 47():1244-50. PubMed ID: 11421053
[TBL] [Abstract][Full Text] [Related]
11. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
12. [Osteoporosis in children and adolescents].
Marcelli C
Presse Med; 2007; 36(7-8):1078-83. PubMed ID: 17395422
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis update from the 2010 santa fe bone symposium.
Lewiecki EM; Bilezikian JP; Khosla S; Marcus R; McClung MR; Miller PD; Watts NB; Maricic M
J Clin Densitom; 2011; 14(1):1-21. PubMed ID: 21295739
[TBL] [Abstract][Full Text] [Related]
14. Understanding osteoporosis.
Javaid MK; Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):38-45. PubMed ID: 18477619
[TBL] [Abstract][Full Text] [Related]
15. Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures.
Arabi A; Baddoura R; Awada H; Khoury N; Haddad S; Ayoub G; El-Hajj Fuleihan G
Bone; 2007 Apr; 40(4):1060-5. PubMed ID: 17223616
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
17. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
18. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Bone metabolism in hematological disorders].
Abe M
Clin Calcium; 2013 Sep; 23(9):1271-7. PubMed ID: 23999362
[TBL] [Abstract][Full Text] [Related]
19. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Vitamin D deficiency and fracture].
Watanabe R; Okazaki R
Clin Calcium; 2013 Sep; 23(9):1313-9. PubMed ID: 23999368
[TBL] [Abstract][Full Text] [Related]
20. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
Nishida A; Ito M
Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
